NDC 45802-717-00 - Terconazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45802-717
- Requested NDC
- 45802-717-00
- Package NDCs from labels
- 45802-717-00, 45802-717-08
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Effective date
- 2026-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Terconazole - Padagis Israel Pharmaceuticals Ltd | Padagis Israel Pharmaceuticals Ltd | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-717-00 | Terconazole | 1 in 1 BLISTER PACK | SUPPOSITORY | 1 | 14 | |
| 45802-717-08 | Terconazole | 3 in 1 CARTON | SUPPOSITORY | 3 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-717-00 | EA - Each | 45802-717 | 2d1becfb-6670-41a8-846b-9532b30b8772 | 1 | 2019-12-10 |
| 45802-717-08 | EA - Each | 45802-717 | 3ee857ff-9984-40ea-873a-73ee5f1db070 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TERCONAZOLE | ACTIVE INGREDIENT | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 | |
| TERCONAZOLE | ACTIVE MOIETY | 0KJ2VE664U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | TERCONAZOLE SUPPOSITORY [PERRIGO NEW YORK INC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terconazole | TERCONAZOLE | Padagis Israel Pharmaceuticals Ltd | 207e9cf2-e8ec-43d7-9c11-46283c9cdb37 | 2026-08-11 | Warnings, Adverse reactions | ANDA077149 45802-717-00 45802-717-08 45802-717 45802071700 198245 006c6bda-594f-46ce-ba64-d075022ed4b4 207e9cf2-e8ec-43d7-9c11-46283c9cdb37 0KJ2VE664U |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | C9H2L21V7U |
| Terconazole | TERCONAZOLE | Cosette Pharmaceuticals, Inc. | 38cd1718-6b3c-415d-a17f-7b399adb0ba2 | 2026-05-07 | Warnings, Adverse reactions | 198245 0KJ2VE664U |
| Terconazole Vaginal Cream 0.8% | TERCONAZOLE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | f59448bd-f730-46d2-a785-c2d6205579ff | 2026-01-28 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 10e84353-93d2-461d-8b79-e9294df047ae | 2026-01-28 | Warnings, Adverse reactions | 0KJ2VE664U |
| Smoflipid | SMOFLIPID | Fresenius Kabi USA, LLC | e0e9d917-ff6f-488e-a6a8-0ad59dd17d80 | 2025-08-15 | Warnings, Adverse reactions | C9H2L21V7U |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | 6d7a8fd6-7837-427e-9b18-89e33351b05e | 2025-07-07 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | b4f50a11-bd39-4023-9145-2da60f6b085f | 2025-07-07 | Warnings, Adverse reactions | 198245 0KJ2VE664U |
| Terconazole | TERCONAZOLE | Sun Pharmaceutical Industries, Inc. | 2b3923b5-0a97-428c-b8d2-4a3ceb3447a1 | 2025-05-27 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | NuCare Pharmaceuticals,Inc. | 71c13149-396e-edc6-e053-2a95a90af50c | 2024-12-24 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | b922feb5-cd85-4f13-9a18-913e58f8da83 | 2023-12-09 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | e0a5e163-741f-4f5e-9d2e-b733f9879c99 | 2023-10-31 | Warnings, Adverse reactions | 0KJ2VE664U |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | C9H2L21V7U |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | C9H2L21V7U |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | C9H2L21V7U |
| Terconazole Vaginal Cream 0.8% | TERCONAZOLE | A-S Medication Solutions | 9b1c38ac-ebf3-471c-bcdf-1ff8ad197f91 | 2023-01-03 | Warnings, Adverse reactions | 0KJ2VE664U |
| Terconazole | TERCONAZOLE | A-S Medication Solutions | 1e32bf0d-2a93-44ac-ae28-8d34e10380c0 | 2023-01-03 | Warnings, Adverse reactions | 0KJ2VE664U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.